Genentech Sues Dr. Reddy's Over Generic Valcyte
Genentech and Roche Palo Alto LLC allege Dr. Reddy's infringed U.S. Patent Number 6,083,953 by seeking U.S. Food and Drug Administration approval for a generic version of Valcyte. It seeks to block the Indian drugmaker from selling its generic in the U.S. before that patent expires.
Valcyte, the name under which Genentech markets tablets containing...
To view the full article, register now.